Chicago – January 22, 2025
As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Joe Biden-era policies won’t make the cut.
On Monday, Trump signed a sweeping order aimed in part at reversing several Biden administration executive orders on health care, including efforts to lower the cost of prescription drugs for people on Medicare and Medicaid, enhancing the Affordable Care Act and increasing protections for Medicaid enrollees. The so-called initial rescissions order, according to the Trump White House, is aimed at Biden policies that it says are “deeply unpopular” and “radical.”
The moves by Trump, experts say, are likely to be inconsequential to many Americans in terms of what they pay in out-of-pocket health care costs.
Biden’s bigger health care initiatives, such as a $35 monthly cap on insulin, a $2,000 annual out-of-pocket cap on prescription drugs and Medicare’s negotiating drug pricing provision weren’t affected by Trump’s executive actions Monday.
